Detection of protein alterations in male breast cancer using two dimensional gel electrophoresis and mass spectrometry: The involvement of several pathways in tumorigenesis

Clinica Chimica Acta

Volumn 388, Issue 1-2, 2008, Pages 106-114

  Chahed, Karim ^a,b   Kabbage, Maria ^a   Hamrita, Bechr ^a   Guillier, Christelle Lemaitre ^c   Trimeche, Mounir ^d   Remadi, Sami ^e   Ehret Sabatier, Laurence ^f   Chouchane, Lotfi ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b UNIVERSITY OF MONASTIR   (Tunisia)

^c CNRS   (France)

^d FARHAT HACHED HOSPITAL   (Tunisia)

^e Laboratoire Cytopath   (Tunisia)

^f UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Infiltrating ductal carcinomas; Male breast cancer; Proteomics

Indexed keywords

CATHEPSIN D; CYCLOPHILIN A; CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; ENOLASE; GALECTIN 1; HEAT SHOCK PROTEIN 27; ISOMERASE; PEROXIREDOXIN; TROPOMYOSIN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER INVASION; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; ISOELECTRIC FOCUSING; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METASTASIS; PH MEASUREMENT; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION;

AMINO ACID SEQUENCE; BREAST NEOPLASMS, MALE; CELL TRANSFORMATION, NEOPLASTIC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 37249045988     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.10.018     Document Type: Article

References (30)

1. Giordano S., Cohen D., Buzdar A., Perkins G., and Hortobagyi G. Breast carcinoma in men. A population-based study. Cancer 101 (2004) 51-57
2. El-Gazayerli M., and Abdel-Aziz A. On bilharziasis and male breast cancer in Egypt. Br J Cancer 17 (1963) 556-571
3. Thorlacius S., Tryggvadottir L., Olafsdottir G., et al. Linkage to BRCA2 region in hereditary male breast cancer. Lancet 346 (1995) 544-545
4. Pich A., Margaria E., and Chiusa L. Bcl-2 expression in male breast carcinoma. Virchows Arch 433 (1998) 229-235
5. kip1 using an immunohistochemical assay. Ann Oncol 13 (2002) 895-902
6. Frangou E., Lawson J., and Kanthan R. Angiogenesis in male breast cancer. World J Surg Oncol (2005) 3-16
7. Basu A., Basu I., Chakraborty A., Pal S., and Chattopadiiyay U. Detection and purification of a novel 72 kDa glycoprotein male breast tumor associated antigen. Int J cancer 105 (2003) 377-383
8. Elston C., and Ellis I. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19 (1991) 403-410
9. Chahed K., Kabbage M., Sabatier L., et al. Expression of fibrinogen E-fragment and fibrinE-fragment is inhibited in the human infiltrating ductal carcinoma of the breast: A two dimensional electrophoresis and MALDI-TOF-mass spectrometry analysis. Int J Oncol 27 (2005) 1425-1432
10. O'Farrell P., Goodman H., and O'Farrell P. High resolution two-dimensional gel electrophoresis of basic proteins as well as acidic proteins. Cell 12 (1977) 1133-1142
11. He Q., Cheung Y., Leung S., Yuen S., Chu K., and Chiu J. Diverse proteomic alterations in gastric adenocarcinoma. Proteomics 4 (2004) 3276-3287
12. Gonias S., Hembrough T., and Sankovik M. Cytokeratin 8 function as a major plasminogen receptor in select epithelial and carcinoma cells. Front Biosci 6 (2001) 1403-1411
13. Ding S., Li Y., Tan Y., et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 3 (2004) 73-81
14. Jung M., Kim S., Jeon G., et al. Identification of differentially expressed genes in normal and tumor human gastric tissue. Genomics 69 (2000) 281-286
15. Mahadev K., Raval G., Bharadwaj S., et al. Suppression of the transformed phenotype of breast cancer by tropomyosin 1. Exp Cell Res 279 (2002) 40-51
16. Franzen B., Linder S., Uryu K., et al. Expression of tropomyosin isoforms in benign and malignant human breast lesions. Br J Cancer 73 (1996) 909-913
17. Kim H., Lee T., Park E., et al. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 275 (2000) 18266-18270
18. Lee S., Hwang Y., Kim Y., et al. Cyclophilin a binds to peroxiredoxins and activates its peroxidase activity. J Biol Chem. 276 (2001) 29826-29832
19. Li M., Zhai Q., Bharadwaj U., et al. Cyclophilin A is overexpressed in human pancreatic cancer cells and stimulates cell proliferation through CD147. Cancer 106 (2006) 2284-2294
20. Clark G., Drugan J., Rossman K., et al. 14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain. J Biol Chem 272 (1997) 20990-20993
21. Hansen R., Parra I., Lemieux P., Oesterreich S., Hilenbeck S., and Fuqua S. HSP27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells. Breast Cancer Res Treat 56 (1999) 187-196
22. Ruiz Z., Jian-Guo J., Hai P., and Bing-Gen R. Use of serological proteomic methods to find biomarkers associated with breast cancer. Proteomics 3 (2003) 433-439
23. Garrido C., Schmitt E., Cande C., Vahsen N., Parcellier A., and Kroemer G. HSP27 and HSP70 : potentially oncogenic apoptosis inhibitors. Cell Cycle 2 (2003) 579-584
24. Oikawa T., Sasaki T., Nakamura M., et al. The proteasome is involved in angiogenesis. Biochem Biophys Res Commun 246 (1998) 243-248
25. Hittelet A., Legendre H., Nagy N., et al. Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration. Int J Cancer 103 (2003) 370-379
26. Mandal M., Vadlamudi R., Nguyen D., et al. Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem 276 (2001) 9699-9704
27. Trabold O., Wagner S., Wicke C., et al. Lactate and oxygen constitute a fundamental regulatory mechanism in wound healing. Wound Rep Reg 11 (2003) 504-509
28. Liu J., Shen J., Tanzillo-Swarts A., et al. Annexin II expression is reduced or lost in prostate cancer cells and its re-expression inhibits prostate cancer cell migration. Oncogene 22 (2003) 1475-1485
29. Gillette J., Chan D., and Nielsen-Preiss S. Annexin 2 expression is reduced in human osteosarcoma metastases. J Cell Biochem 92 (2004) 820-832
30. Bekku S., Mochizuki H., Yamamoto T., et al. Expression of carbonic anhydrase I or II and correlation to clinical aspects of colorectal cancer. Hepatogastroenterology 47 (2000) 998-1001